JP2023506450A - 拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物 - Google Patents

拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物 Download PDF

Info

Publication number
JP2023506450A
JP2023506450A JP2022535512A JP2022535512A JP2023506450A JP 2023506450 A JP2023506450 A JP 2023506450A JP 2022535512 A JP2022535512 A JP 2022535512A JP 2022535512 A JP2022535512 A JP 2022535512A JP 2023506450 A JP2023506450 A JP 2023506450A
Authority
JP
Japan
Prior art keywords
individual
antibody
diastolic dysfunction
obese
therapeutically effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022535512A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506450A5 (https=
Inventor
ショーン マッギー
リアム ホール
ジュリアン チェチョル
Original Assignee
アンベテックス ピーティーワイ エルティーディー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2019904682A external-priority patent/AU2019904682A0/en
Application filed by アンベテックス ピーティーワイ エルティーディー filed Critical アンベテックス ピーティーワイ エルティーディー
Publication of JP2023506450A publication Critical patent/JP2023506450A/ja
Publication of JP2023506450A5 publication Critical patent/JP2023506450A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP2022535512A 2019-12-11 2020-11-20 拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物 Pending JP2023506450A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019904682A AU2019904682A0 (en) 2019-12-11 Compositions and methods for prevention and treatment of cardiovascular disease.
AU2019904682 2019-12-11
PCT/AU2020/051254 WO2021113899A1 (en) 2019-12-11 2020-11-20 Therapeutic compositions comprising an amyloid beta antibody or vaccine for prevention and treatment of diastolic dysfunction

Publications (2)

Publication Number Publication Date
JP2023506450A true JP2023506450A (ja) 2023-02-16
JP2023506450A5 JP2023506450A5 (https=) 2023-12-13

Family

ID=76328764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535512A Pending JP2023506450A (ja) 2019-12-11 2020-11-20 拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物

Country Status (5)

Country Link
US (1) US20230027014A1 (https=)
EP (1) EP4073113A4 (https=)
JP (1) JP2023506450A (https=)
AU (1) AU2020401837A1 (https=)
WO (1) WO2021113899A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230039734A (ko) 2020-07-23 2023-03-21 오타이르 프로테나 리미티드 항-Aβ 항체
WO2025165940A1 (en) * 2024-02-01 2025-08-07 Calviri, Inc. Methods and compositions for reducing non-tumor disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009017467A1 (en) * 2007-07-27 2009-02-05 Elan Pharma International Limited Treatment of amyloidogenic diseases
JP2009519708A (ja) * 2005-12-12 2009-05-21 エーシー イミューン ソシエテ アノニム 治療的特性を有するβ１〜４２特異的モノクローナル抗体
WO2010035261A2 (en) * 2008-09-29 2010-04-01 Ben Gurion University Of The Negev Research And Development Authority Amyloid beta-peptides and methods of use thereof
JP2013521233A (ja) * 2010-02-25 2013-06-10 ヤンセン アルツハイマー イミュノセラピー Ａβを標的とする免疫療法のＰＥＴモニタリング

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200501524A1 (ru) * 2003-03-28 2006-06-30 Сентокор, Инк. Антитела против амилоида, композиции, способы и применения
US20100028351A1 (en) * 2006-06-29 2010-02-04 Marc Mercken Anti-amyloid antibodies, compositions, methods and uses
US20100074901A1 (en) * 2007-10-15 2010-03-25 Marc Hubert Mercken Human anti-amyloid antibodies, compositions, methods and uses
AU2020401838A1 (en) * 2019-12-11 2022-07-21 Ambetex Pty Ltd Therapeutic compositions and methods for prevention and treatment of diastolic dysfunction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009519708A (ja) * 2005-12-12 2009-05-21 エーシー イミューン ソシエテ アノニム 治療的特性を有するβ１〜４２特異的モノクローナル抗体
WO2009017467A1 (en) * 2007-07-27 2009-02-05 Elan Pharma International Limited Treatment of amyloidogenic diseases
WO2010035261A2 (en) * 2008-09-29 2010-04-01 Ben Gurion University Of The Negev Research And Development Authority Amyloid beta-peptides and methods of use thereof
JP2013521233A (ja) * 2010-02-25 2013-06-10 ヤンセン アルツハイマー イミュノセラピー Ａβを標的とする免疫療法のＰＥＴモニタリング

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
心臓, vol. 40, no. 6, JPN6024038996, 2008, pages 561 - 566, ISSN: 0005557841 *

Also Published As

Publication number Publication date
US20230027014A1 (en) 2023-01-26
AU2020401837A1 (en) 2022-07-21
EP4073113A4 (en) 2024-02-14
WO2021113899A1 (en) 2021-06-17
EP4073113A1 (en) 2022-10-19

Similar Documents

Publication Publication Date Title
JP7723649B2 (ja) 抗プロ／潜在型ミオスタチン抗体およびその使用方法
KR20180049075A (ko) 항-프로/잠재성-미오스타틴 항체 및 그의 용도
EP4714494A2 (en) A myostatin pathway inhibitor in combination with a glp-1 pathway activator for use in treating metabolic disorders
KR20110074898A (ko) 염증을 치료하는 방법
JP2017155050A (ja) 慢性又は急性疾患に罹患している患者の体液平衡を調整するための抗アドレノメデュリン（ＡＤＭ）抗体、抗ＡＤＭ抗体フラグメント又は抗ＡＤＭ非Ｉｇ足場
BR112020002155A2 (pt) métodos e composições para o tratamento de doenças de deposição de amiloide
US20190241651A1 (en) Compositions and methods for reducing adiposity by inhibiting fsh/fshr
JP2025020230A (ja) ミオスタチン活性化の阻害により代謝疾患を処置するための方法
Wu et al. A bivalent antihypertensive vaccine targeting L‐type calcium channels and angiotensin AT1 receptors
US20200353079A1 (en) Methods for treating heart failure using glucagon receptor antagonistic antibodies
JP2023506450A (ja) 拡張機能障害の防止及び治療のためのアミロイドベータ抗体又はワクチンを含む療法組成物
Ke et al. A novel vaccine targeting β1-adrenergic receptor
US10144777B2 (en) B-lymphocyte targeting agents for use in a method for the treatment of a disease
JP2025530190A (ja) アルツハイマー病治療のための免疫療法薬とｓｃｙｌｌｏ－イノシトールとの組み合わせ
CN112839672A (zh) 用于减少脂蛋白a形成以及治疗主动脉瓣硬化和主动脉狭窄的组合物和方法
US20260001949A1 (en) Neutralization of acyl-coa binding protein for the treatment of cardiac dysfunction
RU2832323C1 (ru) Способ лечения с использованием антитела против CCL24
WO2015165971A1 (en) Treatment and prevention of alzheimer's disease (ad)
HK40040990A (en) Identification of a new polypeptide hormone for maintenance of optimal body weight and blood glucose
WO2021207667A1 (en) Compositions and methods for treating lung injury or acute respiratory distress syndrome (ards)
JP2023522907A (ja) 抗ｃｃｌ２４抗体を使用する処置方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220610

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231120

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231205

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241001

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250325